Translumina Therapeutics Launches Operations in the UAE
Translumina Therapeutics, the leading company in India's coronary stents market, is thrilled to announce its new operations in the UAE. Founded in 2011, this company has quickly become an essential player in the sales and marketing of coronary intervention devices. Over the years, it has built its own manufacturing capabilities while developing a diverse range of product lines.
Expanding Global Footprint
Translumina has a strong vision to elevate India on the global stage in medical device manufacturing, embracing the motto 'Make in India, Make for the world.' As Gurmit Singh Chugh, Co-Founder and Chairman of Translumina Therapeutics, shares, entering the UAE market is a critical milestone in achieving this goal. He underlines the significance of Indian engineering and innovation within the medical devices field.
Investing in Global Markets
Punita Sharma Arora, Co-Founder & Vice-Chairman, echoed this dedication, pointing out the company’s established presence in multiple international markets. With over five years of experience in Europe and South Asia, Translumina has also begun to make important inroads in Latin America and Southeast Asia. Adding MENA to its portfolio showcases the company’s commitment to enhancing its global reach with a comprehensive range of products.
Technological Innovations
Translumina has developed its drug-eluting stent technologies in collaboration with prominent institutions, including the German Heart Centre. This partnership has led to groundbreaking medical devices that have undergone extensive research for over a decade, yielding significant safety and efficacy data.
Strategic Expansion Through Acquisitions
In its ambitious progression, Translumina has broadened its product range by acquiring Blue Medical, a Dutch firm specializing in drug-coated balloons, along with Lamed, a significant player in Germany's vascular surgery sector. Arjun Oberoi, Managing Director of Everstone Capital and a board member at Translumina, highlighted the strategic foresight behind these partnerships aimed at positioning the company as a global leader.
Strengthening the MENA Presence
Indranil Mukherjee, Group CEO of Translumina, expressed excitement about launching operations in the UAE, which he described as a hub for business innovation and strategic significance. This move will enhance Translumina's ability to serve the MENA region while solidifying its global footprint and commitment to expanding access to high-quality healthcare.
Contact Us
If you have any questions or need additional information about Translumina Therapeutics and its innovative products, please contact:
Dr. Nancy Chugh
Don't hesitate to reach out for further details!
Frequently Asked Questions
What is Translumina Therapeutics?
Translumina Therapeutics is an Indian company that focuses on coronary intervention devices, such as drug-eluting stents.
Where has Translumina recently expanded its operations?
Translumina has just started its direct operations in the UAE.
What is the company’s mission?
The company strives to establish India as a global leader in medical devices, fostering innovation and advanced manufacturing.
What notable partnerships has Translumina formed?
Translumina has teamed up with the German Heart Centre and made strategic acquisitions, including Blue Medical and Lamed, to enhance its product offerings.
How does Translumina contribute to healthcare accessibility?
By expanding its global operations, Translumina seeks to improve access to high-quality healthcare products in various regions.
